KURA Earnings Date: Nov 3, 2026 (Estimated) — Kura Oncology, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is KURA's next earnings date?
Kura Oncology, Inc. (KURA) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.82 on revenue of $24.9M.
How did KURA do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Kura Oncology, Inc. posted EPS of -$0.77 versus the -$0.88 estimate, a beat of 12.5%. Revenue was $20.9M against a $20.2M estimate. The stock's 1-day post-earnings move was +1.5%.
How much does KURA stock move after earnings?
KURA beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 1.1% (up or down) in the day after earnings.
About Kura Oncology, Inc.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.88 | -0.77 | +12.50% | $20.9M | ✅ Beat | +1.51% | +26.06% | +14.59% |
| 2026-05-12 | Q1 2026 | -0.80 | -0.83 | -3.75% | $18.3M | ❌ Miss | -2.07% | -7.44% | -8.47% |
| 2026-03-05 | Q4 2025 | -0.58 | -0.92 | -58.62% | $17.3M | ❌ Miss | -0.47% | +7.84% | +0.70% |
| 2025-11-04 | Q3 2025 | -0.63 | -0.85 | -34.92% | $20.8M | ❌ Miss | +1.94% | +5.63% | +22.52% |
| 2025-02-26 | Q4 2024 | -0.64 | -0.22 | +65.62% | $53.9M | ✅ Beat | -1.54% | -5.15% | -8.11% |
| 2024-11-07 | Q3 2024 | -0.63 | -0.63 | +0.00% | $0 | ➖ Inline | -0.51% | -7.20% | -40.74% |
| 2024-08-08 | Q2 2024 | -0.63 | -0.59 | +6.35% | $0 | ✅ Beat | -0.78% | +1.73% | +2.30% |
| 2024-05-02 | Q1 2024 | -0.55 | -0.59 | -7.27% | $0 | ❌ Miss | +0.19% | +0.87% | +2.91% |
Showing last 8 quarters.